MTND1P33: A Drug Target / Disease Biomarker (G100873218)

Target Name: MTND1P33

NCBI ID: G100873218

MTND1P33

Other Name(s): MT-ND1 pseudogene 33 | Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 33

MTND1P33: A Drug Target / Disease Biomarker

MTND1P33 is a protein that is expressed in the brain and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The protein is composed of 33 amino acids and has a calculated molecular weight of 41 kDa.

Recent studies have identified MTND1P33 as a potential drug target for the treatment of neurodegenerative diseases. This is because the protein is involved in the formation of neurotransmitters, which are the chemical messengers that communicate between neurons in the brain. In neurodegenerative diseases, the ability of neurons to produce neurotransmitters is often compromised, leading to the development of symptoms such as memory loss, confusion, and difficulty with movement.

One of the ways that MTND1P33 is thought to contribute to the development of neurodegenerative diseases is by participating in the formation of amyloid plaques, which are thought to play a role in the development of Alzheimer's disease. Amyloid plaques are composed of abnormal aggregates of the protein beta-amyloid, which are thought to cause the neurotoxicity that occurs in Alzheimer's disease.

Another way that MTND1P33 may contribute to the development of neurodegenerative diseases is by participating in the formation of neurofibrillary tangles, which are thought to play a role in the development of Parkinson's disease. Neurofibrillary tangles are composed of abnormal aggregates of the protein tau, which are thought to cause the neurotoxicity that occurs in Parkinson's disease.

In addition to its role in the formation of amyloid plaques and neurofibrillary tangles, MTND1P33 is also thought to be involved in the regulation of neurotransmitter release. This is because the protein is known to interact with the neurotransmitter transporter, a protein that is responsible for transporting neurotransmitters from the brain to the rest of the body.

Overall, MTND1P33 is a protein that is thought to be involved in the development and progression of neurodegenerative diseases. As such, it is a potential drug target for the treatment of these diseases. Further research is needed to fully understand the role of MTND1P33 in neurodegenerative diseases and to develop effective treatments.

Protein Name: MT-ND1 Pseudogene 33

The "MTND1P33 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND1P33 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets